These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 1419750)

  • 21. Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita.
    Watanabe M; Natsuga K; Shinkuma S; Shimizu H
    J Dermatol; 2018 May; 45(5):515-521. PubMed ID: 29352483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of basement membrane zone antigens during epidermal wound healing in pigs.
    Stanley JR; Alvarez OM; Bere EW; Eaglstein WH; Katz SI
    J Invest Dermatol; 1981 Aug; 77(2):240-3. PubMed ID: 7024426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keratinocytes and fibroblasts from a patient with mutilating dystrophic epidermolysis bullosa synthesize drastically reduced amounts of collagen VII: lack of effect of transforming growth factor-beta.
    König A; Lauharanta J; Bruckner-Tuderman L
    J Invest Dermatol; 1992 Dec; 99(6):808-12. PubMed ID: 1281864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.
    Nakayama C; Fujita Y; Matsumura W; Ujiie I; Takashima S; Shinkuma S; Nomura T; Abe R; Shimizu H
    J Dermatol Sci; 2018 Sep; 91(3):301-310. PubMed ID: 29933899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular accumulation of collagen VII in cultured keratinocytes from a patient with dominant dystrophic epidermolysis bullosa.
    König A; Raghunath M; Steinmann B; Bruckner-Tuderman L
    J Invest Dermatol; 1994 Jan; 102(1):105-10. PubMed ID: 8288900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrillin immunoreactivity is associated with normal or fragmented elastic microfibrils at the dermal-epidermal junction in recessive dystrophic epidermolysis bullosa.
    McGrath JA; Sakai LY; Eady RA
    Br J Dermatol; 1994 Oct; 131(4):465-71. PubMed ID: 7947198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplanted bone marrow-derived circulating PDGFRα+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft.
    Iinuma S; Aikawa E; Tamai K; Fujita R; Kikuchi Y; Chino T; Kikuta J; McGrath JA; Uitto J; Ishii M; Iizuka H; Kaneda Y
    J Immunol; 2015 Feb; 194(4):1996-2003. PubMed ID: 25601922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous reactivity with LH7.2 and the first prenatal diagnosis of generalized recessive dystrophic epidermolysis bullosa among Japanese patients.
    Shimizu H; Suzumori K; Nishikawa T
    Dermatology; 1996; 192(3):203-7. PubMed ID: 8726631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraepidermal expression of basement membrane components in the lesional skin of a patient with dystrophic epidermolysis bullosa.
    Muramatsu T; Ko T; Honoki K; Hatoko M; Shirai T; Vnittanakom P
    J Dermatol; 1999 Feb; 26(2):106-10. PubMed ID: 10091480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical, ultrastructural, and molecular features of Kindler syndrome distinguish it from dystrophic epidermolysis bullosa.
    Shimizu H; Sato M; Ban M; Kitajima Y; Ishizaki S; Harada T; Bruckner-Tuderman L; Fine JD; Burgeson R; Kon A; McGrath JA; Christiano AM; Uitto J; Nishikawa T
    Arch Dermatol; 1997 Sep; 133(9):1111-7. PubMed ID: 9301588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations.
    van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF
    J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa.
    Conget P; Rodriguez F; Kramer S; Allers C; Simon V; Palisson F; Gonzalez S; Yubero MJ
    Cytotherapy; 2010 May; 12(3):429-31. PubMed ID: 20230217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superficial dermal fibroblasts enhance basement membrane and epidermal barrier formation in tissue-engineered skin: implications for treatment of skin basement membrane disorders.
    Varkey M; Ding J; Tredget EE
    Tissue Eng Part A; 2014 Feb; 20(3-4):540-52. PubMed ID: 24004160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.
    Pourreyron C; Cox G; Mao X; Volz A; Baksh N; Wong T; Fassihi H; Arita K; O'Toole EA; Ocampo-Candiani J; Chen M; Hart IR; Bruckner-Tuderman L; Salas-Alanis JC; McGrath JA; Leigh IM; South AP
    J Invest Dermatol; 2007 Oct; 127(10):2438-44. PubMed ID: 17495952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three new cases of transient bullous dermolysis of the newborn.
    Hanson SG; Fine JD; Levy ML
    J Am Acad Dermatol; 1999 Mar; 40(3):471-6. PubMed ID: 10071321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis.
    Heagerty AH; Kennedy AR; Leigh IM; Purkis P; Eady RA
    Br J Dermatol; 1986 Aug; 115(2):125-31. PubMed ID: 3527251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants.
    Dang N; Klingberg S; Marr P; Murrell DF
    J Dermatol Sci; 2007 Jun; 46(3):169-78. PubMed ID: 17425959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue.
    Siprashvili Z; Nguyen NT; Bezchinsky MY; Marinkovich MP; Lane AT; Khavari PA
    Hum Gene Ther; 2010 Oct; 21(10):1299-310. PubMed ID: 20497034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa.
    Venugopal SS; Yan W; Frew JW; Cohn HI; Rhodes LM; Tran K; Melbourne W; Nelson JA; Sturm M; Fogarty J; Marinkovich MP; Igawa S; Ishida-Yamamoto A; Murrell DF
    J Am Acad Dermatol; 2013 Dec; 69(6):898-908.e7. PubMed ID: 24075228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracytoplasmic retention of type VII collagen and dominant dystrophic epidermolysis bullosa: reversal of defect following cessation of or marked improvement in disease activity.
    Fine JD; Johnson LB; Cronce D; Wright JT; Leigh IM; McCollough M; Briggaman RA
    J Invest Dermatol; 1993 Aug; 101(2):232-6. PubMed ID: 8345225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.